nedocromil has been researched along with Cardiac Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, K; Inatome, T; Kawai, K; Kawashima, S; Kitazaki, K; Miyazaki, T; Mori, M; Shirotani, T; Tajiri, E; Yamabe, H; Yokoyama, M | 1 |
| Janicki, JS; Levick, SP; Lu, H; Meléndez, GC | 1 |
| Brower, GL; Janicki, JS | 1 |
3 other study(ies) available for nedocromil and Cardiac Failure
| Article | Year |
|---|---|
Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients.
Topics: Aged; beta 2-Microglobulin; Biomarkers; Blood Pressure; Body Mass Index; Creatinine; Echocardiography; Female; Glomerular Filtration Rate; Heart Failure; Humans; Male; Nedocromil; Prognosis; Pulmonary Disease, Chronic Obstructive; Recurrence | 2010 |
Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype.
Topics: Animals; Anti-Inflammatory Agents; Cardiomegaly; Collagen; Endothelin-1; Estrogens; Female; Heart Failure; Mast Cells; Nedocromil; Ovariectomy; Phenotype; Rats; Rats, Sprague-Dawley; Stem Cell Factor; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2012 |
Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats.
Topics: Animals; Anti-Inflammatory Agents; Cell Degranulation; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Failure; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Mast Cells; Myocardial Contraction; Nedocromil; Organ Size; Rats; Rats, Sprague-Dawley; Stroke Volume; Vasodilation; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2005 |